Creative Planning Outlook Therapeutics, Inc. Transaction History

Creative Planning

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.22 - $0.66 $84 - $252	383 Added 1.78%	21,883 $8,000
Q2 2023 Jul 21, 2023	SELL	$1.02 - $1.89 $1,530 - $2,835	-1,500 Reduced 6.52%	21,500 $37,000
Q2 2021 Aug 04, 2021	SELL	$1.78 - $2.76 $1,178 - $1,827	-662 Reduced 2.8%	23,000 $57,000
Q2 2020 Jul 23, 2020	BUY	$0.56 - $1.41 $3,360 - $8,460	6,000 Added 33.97%	23,662 $31,000
Q1 2020 May 05, 2020	BUY	$0.51 - $1.08 $9,007 - $19,074	17,662 New	17,662 $11,000

67.1K

Ticker OTLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,144,992
Market Cap $1.66B
Description
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.